Your browser doesn't support javascript.
loading
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS.
Li, Jieni; Chikermane, Soumya G; Earla, Jagadeswara R; Hutton, George J; Aparasu, Rajender R.
Afiliación
  • Li J; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Texas, USA.
  • Chikermane SG; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Texas, USA.
  • Earla JR; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Texas, USA.
  • Hutton GJ; Baylor College of Medicine, Houston, Texas.
  • Aparasu RR; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Texas, USA. Electronic address: rraparasu@uh.edu.
Mult Scler Relat Disord ; 60: 103703, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35278846

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...